by admin | Jun 5, 2024 | News
Joana Correia, Founder and CEO of Exogenus Therapeutics, will be a featured speaker at Exosomes Europe, taking place in London on June 5th and 6th. Joana will present a talk titled “Extracellular vesicles in human health: opportunities and challenges,”...
by admin | Apr 29, 2024 | Careers
COMPANY DESCRIPTION Exogenus Therapeutics is a biotechnology company dedicated to advancing innovative healthcare solutions based on extracellular vesicles (EV). Our work focuses on three main areas: Therapeutic development, with our flagship Exo-101 at the center,...
by admin | Apr 29, 2024 | Careers
COMPANY DESCRIPTION Exogenus Therapeutics is a biotechnology company dedicated to advancing innovative healthcare solutions based on extracellular vesicles (EV). Our work focuses on three main areas: Therapeutic development, with our flagship Exo-101 at the center,...
by admin | Apr 29, 2024 | Careers
COMPANY DESCRIPTION Exogenus Therapeutics is a biotechnology company dedicated to advancing innovative healthcare solutions based on extracellular vesicles (EV). Our work focuses on three main areas: Therapeutic development, with our flagship Exo-101 at the center,...
by admin | Apr 24, 2024 | News
Exogenus Therapeutics is proud to announce a strategic investment led by 3xP Global. This funding of 3xP Global will significantly advance the development of Exogenus lead product, Exo-101, that derived from umbilical cord blood cells and has shown promise in multiple...
